Opportunity Information: Apply for PA 11 347
Apply for PA 11 347
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NINDS SBIR Technology Transfer (SBIR TT R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.233 National Center on Sleep Disorders Research 93.837 Cardiovascular Diseases Research 93.838 Lung Diseases Research 93.839 Blood Diseases and Resources Research 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders 93.867 Vision Research.
- This funding opportunity was created on Jul 18, 2014 and posted on Sep 22, 2011.
- Applicants must submit their applications by Jul 19, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NINDS SBIR Technology Transfer (SBIR TT R43/R44) opportunity, listed under Funding Opportunity Number PA 11-347, is a National Institutes of Health (NIH) grant program designed to help small businesses move promising inventions from NIH intramural laboratories into the private sector. The central goal is technology transfer: taking government-developed biomedical and health-related innovations that already exist within NIH labs and enabling a Small Business Concern (SBC) to further develop them into real-world commercial products that ultimately benefit patients and the public. In other words, this announcement is aimed at bridging the gap between discovery inside NIH and product development in industry by giving qualified small businesses funding support and a pathway to use NIH-owned technologies.
This is an SBIR grant mechanism, meaning it supports early-stage research and development carried out by eligible small businesses, typically through the SBIR phased structure associated with R43/R44 awards. While the source text does not lay out the full phase details, the R43/R44 format generally aligns with feasibility work and early proof-of-concept efforts followed by more advanced development steps. The distinctive feature here is that the supported project is explicitly tied to transferring an NIH intramural technology out into the marketplace, rather than starting from scratch with a company-owned invention. The program encourages companies to identify an NIH-held technology that fits a commercial need, propose a development plan, and use SBIR funding to advance it toward a product.
A key incentive included in the program is licensing access to NIH technologies. If an SBC is selected for SBIR funding under this FOA, it will be granted a royalty-free, non-exclusive internal research use license for the duration of the SBIR award and within the specific field of use tied to the award. This licensing arrangement is meant to lower barriers for companies that want to evaluate, validate, and develop NIH-owned inventions during the funded period. The expectation is that the small business will take concrete steps to mature the invention into a commercial product, positioning it for later-stage investment, regulatory planning where applicable, manufacturing scale-up, partnerships, or additional funding that leads to public impact.
Administratively, this opportunity is categorized as discretionary funding and uses the grant funding instrument. The sponsoring agency is the National Institutes of Health. The activity category is health, and the program is connected to multiple CFDA numbers spanning sleep disorders research (93.233), cardiovascular diseases (93.837), lung diseases (93.838), blood diseases and resources (93.839), neurosciences and neurological disorders research programs (93.853), and vision research (93.867). Even though the title highlights NINDS and technology transfer, these CFDA references suggest the underlying research and potential technologies may span a broad biomedical scope, including neurology-focused innovations as well as related areas that overlap with neurological function or comorbid conditions.
Eligibility is limited to small businesses, consistent with SBIR rules, and there is no cost sharing or matching requirement, which can be important for early-stage companies that need non-dilutive capital without having to provide matching funds. The listed award ceiling in the provided data is $150,000, which can be interpreted as a cap for at least one stage or component as presented in the summary data (SBIR awards often have phase-based budgets and specific NIH policy caps, but the number here is what is explicitly provided in the source).
Timing details in the record indicate the FOA was posted on September 22, 2011, with later record creation dated July 18, 2014. The original closing date is shown as September 7, 2014, and the current closing date is shown as July 19, 2014, with an archive date of August 19, 2014. Practically, this means the announcement is historical/archived rather than currently open, but the structure and intent are still useful as a model for similar NIH technology transfer-focused SBIR efforts.
For further information, the announcement points to the NIH Grants Guide page (http://grants.nih.gov/grants/guide/pa-files/PA-11-347.html). For access or technical issues, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV, specifically for difficulties accessing or linking to the announcement electronically.
Overall, this FOA is best understood as a targeted commercialization pipeline tool: it encourages small businesses to take NIH intramural inventions, secure a limited research-use license during the grant term, and apply SBIR-funded R&D to transform those inventions into products that can be deployed outside government labs for public benefit.
Frequently Asked Questions (FAQs): NINDS SBIR Technology Transfer (SBIR TT R43/R44) - PA 11-347
What is this funding opportunity?
This opportunity is the NINDS SBIR Technology Transfer (SBIR TT R43/R44) program under Funding Opportunity Number (FON) PA 11-347. It is a National Institutes of Health (NIH) grant program intended to help small businesses move promising inventions from NIH intramural laboratories into the private sector.
What is the main purpose of PA 11-347?
The central goal is technology transfer: taking biomedical and health-related innovations that already exist within NIH intramural labs and enabling a Small Business Concern (SBC) to further develop them into real-world commercial products that benefit patients and the public.
Who is the sponsoring agency?
The sponsoring agency is the National Institutes of Health (NIH).
What type of funding is this (grant vs. contract)?
This opportunity uses the grant funding instrument and is categorized as discretionary funding.
What kind of projects does this program support?
It supports early-stage research and development carried out by eligible small businesses to advance NIH intramural technologies toward commercialization. A distinctive feature is that the supported project is explicitly tied to transferring an NIH-owned technology into the marketplace, rather than starting from a company-owned invention.
What does "SBIR TT" mean in this context?
SBIR TT refers to an SBIR technology transfer focus: the program encourages small businesses to identify an NIH-held technology, propose a development plan, and use SBIR funding to advance it toward a commercial product.
What award mechanisms are referenced?
The announcement references the SBIR phased structure associated with R43/R44 awards. While the provided information does not list full phase details, R43/R44 generally aligns with feasibility and early proof-of-concept work followed by more advanced development steps.
Who is eligible to apply?
Eligibility is limited to small businesses, consistent with SBIR rules. The opportunity is intended for a Small Business Concern (SBC).
Is cost sharing or matching required?
No. The provided information states there is no cost sharing or matching requirement.
What is the award ceiling listed in the provided summary?
The listed award ceiling in the provided data is $150,000.
What is the key incentive related to NIH technologies?
If an SBC is selected for SBIR funding under this FOA, it will be granted a royalty-free, non-exclusive internal research use license for the duration of the SBIR award and within the specific field of use tied to the award.
What does the royalty-free, non-exclusive internal research use license allow?
Based on the information provided, the license is intended to lower barriers for companies to evaluate, validate, and develop NIH-owned inventions during the funded period. It applies only for internal research use, lasts for the duration of the SBIR award, and is limited to the specific field of use connected to the award.
Does this program fund brand-new company inventions?
This FOA is framed around transferring an existing NIH intramural technology out into the marketplace. The emphasis is on developing NIH-owned technologies rather than starting from scratch with a company-owned invention.
What outcomes does NIH expect from funded projects?
The expectation is that the small business will take concrete steps to mature the NIH invention into a commercial product. The description highlights positioning the project for later-stage investment, regulatory planning where applicable, manufacturing scale-up, partnerships, or additional funding that leads to public impact.
What is the activity category for this opportunity?
The activity category is health.
Which CFDA numbers are associated with this program?
The program is connected to multiple CFDA numbers: 93.233 (sleep disorders research), 93.837 (cardiovascular diseases), 93.838 (lung diseases), 93.839 (blood diseases and resources), 93.853 (neurosciences and neurological disorders research programs), and 93.867 (vision research).
Does the opportunity only cover neurological technologies?
While the title highlights NINDS and technology transfer, the CFDA references suggest the underlying research and potential technologies may span a broad biomedical scope, including neurology-focused innovations and related areas that overlap with neurological function or comorbid conditions.
When was the FOA posted?
The record indicates the FOA was posted on September 22, 2011.
What are the closing and archive dates shown in the record?
The original closing date is shown as September 7, 2014. The current closing date is shown as July 19, 2014. The archive date is August 19, 2014.
Is this funding opportunity currently open?
Based on the provided timing details and the archive date, this announcement appears to be historical/archived rather than currently open.
Where can applicants or interested parties find the official announcement text?
The announcement points to the NIH Grants Guide page: http://grants.nih.gov/grants/guide/pa-files/PA-11-347.html
Who should be contacted for technical issues accessing the announcement online?
For difficulties accessing or linking to the announcement electronically, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Beginning Farmer Rancher Development Program
Previous opportunity: Interventions for Health Promotion and Disease Prevention in Native American Populations (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 11 347
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 11 347) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIDCR Limited Competition Renewals of Existing Cooperative Agreement Awards, Prospective Studies on Craniofacial Pain and Dysfunction RFA DE 05 007 (U01) Apply for PAR 11 348 Funding Number: PAR 11 348 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Collaborative Hubs for International Research on Mental Health (U19) Apply for RFA MH 12 110 Funding Number: RFA MH 12 110 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Tuskegee University Apology Commemoration Activities Apply for CDC RFA PS12 1202 Funding Number: CDC RFA PS12 1202 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $180,000 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Wisconsin) Apply for PA FPH 12 012 Funding Number: PA FPH 12 012 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $3,671,742 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (West Virginia) Apply for PA FPH 12 013 Funding Number: PA FPH 12 013 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $2,405,407 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Pennsylvania, Western, Northeastern, and Central) Apply for PA FPH 12 014 Funding Number: PA FPH 12 014 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $3,941,586 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Georgia) Apply for PA FPH 12 015 Funding Number: PA FPH 12 015 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $8,229,100 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Kentucky) Apply for PA FPH 12 016 Funding Number: PA FPH 12 016 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $5,621,689 |
| Dynamics of Host Associated Microbial Communities (R01) Apply for RFA GM 13 001 Funding Number: RFA GM 13 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Tennessee) Apply for PA FPH 12 017 Funding Number: PA FPH 12 017 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $6,535,476 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (South Carolina) Apply for PA FPH 12 018 Funding Number: PA FPH 12 018 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $5,881,569 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (North Carolina) Apply for PA FPH 12 019 Funding Number: PA FPH 12 019 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $7,323,350 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (South Dakota) Apply for PA FPH 12 020 Funding Number: PA FPH 12 020 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,065,208 |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Federated States of Micronesia) Apply for PA FPH 12 021 Funding Number: PA FPH 12 021 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $345,000 |
| Short Courses on Mathematical, Statistical, and Computational Tools for Studying Biological Systems (R25) Apply for PA 11 351 Funding Number: PA 11 351 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| HIV Care Grant Program Part B Apply for HRSA 12 132 Funding Number: HRSA 12 132 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Longitudinal Studies on the Impact of Adolescent Drinking on the Adolescent Brain (Phase II) (U01) Apply for RFA AA 12 006 Funding Number: RFA AA 12 006 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Expanding the Encyclopedia of DNA Elements (ENCODE) in the Human and Model Organisms (U54) Apply for RFA HG 11 024 Funding Number: RFA HG 11 024 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Analysis and Coordination Center for the Encyclopedia of DNA Elements (ENCODE) (U41) Apply for RFA HG 11 026 Funding Number: RFA HG 11 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Computational Analysis of the Encyclopedia of DNA Elements (ENCODE) Data (U01) Apply for RFA HG 11 025 Funding Number: RFA HG 11 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 11 347", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
